References
- Rau R. Is remission in rheumatoid arthritis associated with radiographic healing? Clin Exp Rheumatol. 2006;24(6 Suppl 43):S41–S4.
- Kaneko A, Matsushita I, Kanbe K, Arai K, Kuga Y, Abe A, et al. Development and validation of a new radiographic scoring system to evaluate bone and cartilage destruction and healing of large joints with rheumatoid arthritis: ARASHI (Assessment of Rheumatoid Arthritis by Scoring of large joint destruction and Healing in radiographic Imaging) study. Mod Rheumatol. 2013;23:1053–62.
- Figueiredo CP, Simon D, Englbrecht M, Haschka J, Kleyer A, Bayat S, et al. Quantification and impact of secondary osteoarthritis in patients with anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol. 2016;68(9):2114–21.
- Aschenberg S, Finzel S, Schmidt S, Kraus S, Engelke K, Englbrecht M, et al. Catabolic and anabolic periarticular bone changes in patients with rheumatoid arthritis: a computed tomography study on the role of age, disease duration and bone markers. Arthritis Res Ther. 2013;15(3):R62.
- Terkeltaub R, Esdaile J, Décary F, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheumatol. 1983;10(3):418–24.
- Plant MJ, Williams AL, O'Sullivan MM, Lewis PA, Coles EC, Jessop JD. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum. 2000;43(7):1473–7.
- Cabral AR, Loya BL, Alarcón-Segovia D. Bone remodeling and osteophyte formation after remission of rheumatoid arthritis. J Rheumatol. 1989;16(11):1421–7.
- Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102(2):274–82.
- Pelletier JP, Martel-Pelletier J. Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis. Arthritis Care Res. 1989;32(2):181–93.
- Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960–77.